Immunogenic anti-cancer chemotherapy as an emerging concept
- 31 October 2008
- journal article
- review article
- Published by Elsevier BV in Current Opinion in Immunology
- Vol. 20 (5), 545-557
- https://doi.org/10.1016/j.coi.2008.05.008
Abstract
No abstract availableKeywords
This publication has 96 references indexed in Scilit:
- Photodynamic therapy plus low-dose cyclophosphamide generates antitumor immunity in a mouse modelProceedings of the National Academy of Sciences of the United States of America, 2008
- NKG2D-Deficient Mice Are Defective in Tumor Surveillance in Models of Spontaneous MalignancyImmunity, 2008
- Intrinsic sensor of oncogenic transformation induces a signal for innate immunosurveillanceProceedings of the National Academy of Sciences of the United States of America, 2008
- Immunological aspects of cancer chemotherapyNature Reviews Immunology, 2008
- Molecular characteristics of immunogenic cancer cell deathCell Death & Differentiation, 2007
- Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapyNature Medicine, 2007
- Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomasNature, 2007
- Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patientsCancer Immunology, Immunotherapy, 2006
- Anticancer activities of histone deacetylase inhibitorsNature Reviews Drug Discovery, 2006
- Identification of a factor that links apoptotic cells to phagocytesNature, 2002